Benefits Pro12d
Wegovy and other GLP-1s curb demand for bariatric surgery: JAMA study
About 6% of Americans with obesity and without diabetes have had surgery or taken GLP-1 agonists, the research team estimates ...
Lexaria announces partial 12-week blood sugar results from GLP-1 diabetes study
Lexaria Bioscience (LEXX) received partial 12-week blood sugar results from the recently completed animal study WEIGHT-A24-1. The company said, ...
Lexaria Bioscience announces partial 12-week results from WEIGHT-A24-1 study
Lexaria Bioscience (LEXX) has received partial 12-week body weight results from the recently completed animal study WEIGHT-A24-1. Lexaria is ...